Zdrowie i gospodarka · 26/09/2018
FDA Announces Fee Rate for Using Material Threat Medical Countermeasure Priority Review Voucher for FY 2019
The FDA is setting a fee for using a material threat medical countermeasure priority review voucher for FY 2019, based on the average cost of reviewing priority review applications versus non-priority review applications from the previous year.
Source: Federal Register — Food and Drug AdministrationOpen original release →